MTP943B - Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it - Google Patents

Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it

Info

Publication number
MTP943B
MTP943B MT943A MTP943A MTP943B MT P943 B MTP943 B MT P943B MT 943 A MT943 A MT 943A MT P943 A MTP943 A MT P943A MT P943 B MTP943 B MT P943B
Authority
MT
Malta
Prior art keywords
resenate
carboxyde
substituted
preparation
acid
Prior art date
Application number
MT943A
Other languages
English (en)
Inventor
Jatish Chandra Dr Klanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MTP943B publication Critical patent/MTP943B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
MT943A 1983-01-12 1984-01-05 Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it MTP943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (de) 1983-01-12 1983-01-12

Publications (1)

Publication Number Publication Date
MTP943B true MTP943B (en) 1984-06-05

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
MT943A MTP943B (en) 1983-01-12 1984-01-05 Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it

Country Status (41)

Country Link
US (1) US4510128A (de)
EP (1) EP0122219B1 (de)
JP (1) JPS59134759A (de)
KR (1) KR900006747B1 (de)
AR (1) AR240310A1 (de)
AT (2) AT391467B (de)
AU (1) AU570230B2 (de)
BE (1) BE898649A (de)
CA (1) CA1218077A (de)
CH (1) CH655507B (de)
CS (1) CS269954B2 (de)
DD (1) DD218373A5 (de)
DE (2) DE3474152D1 (de)
DK (1) DK166683B1 (de)
DZ (1) DZ593A1 (de)
EG (1) EG16562A (de)
ES (1) ES528770A0 (de)
FI (1) FI82682C (de)
FR (1) FR2542735B1 (de)
GB (1) GB2134529B (de)
GR (1) GR79793B (de)
HK (1) HK90390A (de)
HU (1) HU190750B (de)
IE (1) IE56545B1 (de)
IL (1) IL70660A (de)
IT (1) IT1177501B (de)
LU (1) LU85171A1 (de)
MA (1) MA20000A1 (de)
MC (1) MC1564A1 (de)
MT (1) MTP943B (de)
NL (1) NL8400098A (de)
NO (1) NO162862C (de)
NZ (1) NZ206815A (de)
OA (1) OA07628A (de)
PH (1) PH21795A (de)
PL (1) PL142737B1 (de)
PT (1) PT77932B (de)
RO (1) RO88481A (de)
SE (1) SE457959B (de)
ZA (1) ZA84212B (de)
ZW (1) ZW484A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
CH675537A5 (de) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
CA2112751A1 (en) * 1991-07-03 1993-01-21 Charles J. Ii Betlach Composition and method for transdermal delivery of diclofenac
EP1250937B1 (de) * 2001-04-09 2009-05-13 Rohm And Haas Company Kontrollierte Auflösung von Wirkstoffen
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP1830851A2 (de) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Schnell auflösende zusammensetzung mit maskiertem geschmack und herstellungsverfahren dafür
RU2435569C2 (ru) 2006-03-16 2011-12-10 Трис Фарма, Инк. Композиции с модифицированным высвобождением, содержащие комплексы лекарственное вещество - ионообменная смола
US7799347B2 (en) * 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
JP5670336B2 (ja) * 2008-10-02 2015-02-18 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 全身性炎症の治療のためのポリマー吸着剤の投与
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
DK2884961T3 (en) 2012-08-15 2019-04-23 Tris Pharma Inc METHYLPHENIDATE TABLE WITH EXTENDED RELEASE
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
CN113395960A (zh) 2018-11-19 2021-09-14 爵士制药爱尔兰有限公司 抗酒精药物制剂
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
NO125724B (de) * 1967-12-20 1972-10-23 Ciba Geigy Ag
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
NL8400098A (nl) 1984-08-01
DZ593A1 (fr) 2004-09-13
ZW484A1 (en) 1984-08-08
AT391467B (de) 1990-10-10
PL245656A1 (en) 1985-01-02
KR900006747B1 (ko) 1990-09-20
DD218373A5 (de) 1985-02-06
SE8400098D0 (sv) 1984-01-10
HUT34151A (en) 1985-02-28
MC1564A1 (fr) 1984-11-12
JPH0257058B2 (de) 1990-12-03
FI82682B (fi) 1990-12-31
JPS59134759A (ja) 1984-08-02
AR240310A1 (es) 1990-03-30
NO162862B (no) 1989-11-20
IE56545B1 (en) 1991-08-28
AU570230B2 (en) 1988-03-10
SE8400098L (sv) 1984-07-13
MA20000A1 (fr) 1984-10-01
PH21795A (en) 1988-02-29
RO88481A (ro) 1986-01-30
DE3474152D1 (en) 1988-10-27
CS269954B2 (en) 1990-05-14
NO162862C (no) 1990-02-28
GB8400251D0 (en) 1984-02-08
OA07628A (fr) 1985-05-23
GB2134529B (en) 1986-09-24
CS17884A2 (en) 1989-10-13
PT77932A (en) 1984-02-01
EP0122219B1 (de) 1988-09-21
ATE37378T1 (de) 1988-10-15
DE3400491C2 (de) 1988-11-10
IL70660A (en) 1987-08-31
IT1177501B (it) 1987-08-26
BE898649A (fr) 1984-07-11
LU85171A1 (de) 1984-10-24
PT77932B (en) 1986-07-22
US4510128A (en) 1985-04-09
HK90390A (en) 1990-11-09
CH655507B (de) 1986-04-30
PL142737B1 (en) 1987-11-30
ATA784A (de) 1990-04-15
ZA84212B (en) 1984-08-29
GB2134529A (en) 1984-08-15
SE457959B (sv) 1989-02-13
GR79793B (de) 1984-10-31
IL70660A0 (en) 1984-04-30
CA1218077A (en) 1987-02-17
DK11884A (da) 1984-07-13
IE840049L (en) 1984-07-12
IT8447527A0 (it) 1984-01-10
NO840090L (no) 1984-07-13
DK166683B1 (da) 1993-06-28
FI82682C (fi) 1991-04-10
DK11884D0 (da) 1984-01-11
HU190750B (en) 1986-10-28
EP0122219A3 (en) 1985-05-08
EP0122219A2 (de) 1984-10-17
EG16562A (en) 1991-12-30
FR2542735A1 (fr) 1984-09-21
FR2542735B1 (fr) 1986-04-18
KR840007562A (ko) 1984-12-08
ES8504849A1 (es) 1985-05-01
ES528770A0 (es) 1985-05-01
FI840069A (fi) 1984-07-13
DE3400491A1 (de) 1984-07-12
FI840069A0 (fi) 1984-01-09
AU2323084A (en) 1984-07-19
NZ206815A (en) 1986-08-08

Similar Documents

Publication Publication Date Title
MTP943B (en) Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it
IL69347A0 (en) Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69601A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL76591A0 (en) Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
DE3468030D1 (en) 13-alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
ZA8410057B (en) New 2-phenyl-imidazoles,the preparation thereof and pharmaceutical compositions containing these compounds
IL71475A0 (en) N-aryl-alpha-amino-carboxamides,their preparation and pharmaceutical compositions containing them
IL72725A (en) Stigmast-3beta-yloxyphosphorylcholine and analogues thereof,their manufacture and pharmaceutical compositions containing them
IL71481A0 (en) Substituted indeno-pyridazinones,their preparation and pharmaceutical compositions containing them
IL71419A0 (en) Phenylaminobenzenealkanols,their preparation and pharmaceutical compositions containing them
IL72123A0 (en) Substituted phenylalkyl-piperazinyl-and homopiperazinyl-propyl-ureas and-thioureas,their preparation and pharmaceutical compositions containing them
GB2201676B (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
IL72307A0 (en) Pyridinyl-2-pyrimidinamines,their preparation and pharmaceutical compositions containing them
IL71110A (en) Azolylmethylcycloalkanes,their preparation and fungicidal and pharmaceutical compositions containing them
IL71661A0 (en) 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them
IL72831A0 (en) 2-aminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
IL71657A0 (en) Substituted piperazin-1-yl-acetic acid amides,their preparation and pharmaceutical compositions containing them
IL72079A (en) 4-benzoyl-5-hydroxy-1-benzocyclobutenecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL68520A0 (en) 5-oxo-2-pyrrolidinepropanoic acid and derivatives thereof,their preparation and pharmaceutical compositions containing them
GB2138422B (en) Diphenylazomethines, their preparation and pharmaceutical compositions containing them
IL72678A0 (en) Aminoalkyl-imidazothiadiazole-alkenecarboxylic acid amides,their preparation and pharmaceutical compositions containing them
IL74616A0 (en) Substituted isochromanes and benzoxepines,and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL78963A0 (en) N-phenyl-1-piperazine carboxamidines and related compounds,their preparation and pharmaceutical compositions containing them
IL72008A0 (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols,their preparation and pharmaceutical compositions containing them